GLP-1 manufacturer Biosimilar CDMO and Sterile injectable 506e Outsourcing Facility
Executive Capability Sheet: MayMag Biologics
Company Overview: MayMag Biologics (formerly operating as Zeptide Pharma and Tirzepatide Pharma) is a premier U.S.-based cGMP pharmaceutical and biosimilar manufacturer.
1. Manufacturing Scope & Strategic Positioning
506(e) Industrial Focus: Unlike 503B retail/clinical compounding pharmacies, MayMag Biologics focuses exclusively on industrial, high-volume production of generic drugs and biosimilar biologics on the FDA Drug Shortage list.
Commercial Scale Fill-Finish: High-throughput sterile fill-finish operations engineered to preserve batch stability, integrity, and shelf-life throughout large-scale national distribution.
In-House Device Integration: Direct contract manufacturing and integration of proprietary 510(k) auto-injector pens and delivery hardware.
2. Regulatory Compliance & Quality Assurance
FDA Status: FDA-Registered cGMP 506(e) Manufacturing Facility.
Inspection Record: Clean FDA Form 483 history and zero warning letters.
Quality Standards: Fully compliant with ISO 13485 (Medical Devices), cGMP, USP
<797>, and USP<800>guidelines for sterile compounding and biomanufacturing.Supply Continuity: Multi-year, dual-sourced auto-pen supply agreements to insulate wholesale channels from single-point device failures.
3. Core Product & CDMO Lines for Distributors
| Product Category | Manufacturing Focus & Offerings |
| Insulin & Biosimilars | Large-scale formulation and fill-finish of Insulin 70/30 auto-pens, Insulin Aspart premix/vials, Insulin Glargine, and multi-dose KwikPen-style devices. |
| GLP-1 & Metabolic Biologics | Commercial-grade sterile injectable semaglutide and tirzepatide formulations, customized GLP-1 peptides, and oral GLP-1 therapeutics. |
| Auto-Injectors & Emergency Medicine | Epinephrine auto-injectors (EpiPen equivalents) and anti-inflammatory rheumatoid arthritis (RA) delivery systems. |
| Ophthalmics & Inhalation | High-purity sterile glaucoma treatments, nasal sprays, and inhalation therapeutics. |
| Bacteriostatic Water & Diluents | Industrial-scale production of Bacteriostatic Water for Injection (BWFI) with 0.9% benzyl alcohol preservative for multi-dose applications. |
4. Distributor Value Proposition
Margin Protection: Streamlined U.S. manufacturing efficiency yields competitive, predictable unit economics designed to protect distribution margins from price erosion.
Domestic Supply Security: 100% U.S.-based facility eliminates long lead times and international shipping vulnerabilities during national drug shortages.
Private Label & OEM Services: Full white-label and contract manufacturing (CMO/CDMO) options for private-label distributor portfolios.
Contact & Credentials Validation
Commercial Inquiries:
cdmo@tirzepatidepharm.com|(469) 334-3372Validation & Catalog:
|maymagbiologics.com peptidences.com
Comments
Post a Comment